SEC Form D · Amendment · filed July 14, 2021
Claris Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Meredith C. Fisher · Jersey City, NJDirectorAnton C. Atwell · Jersey City, NJExec · DirectorReza C. Dana · Jersey City, NJDirectorMarc C. De Garidel · Jersey City, NJDirectorKenneth C. Harrison · Jersey City, NJDirectorTerese Gieselman · Vancouver, British Columbia, CanadaDirectorVanessa Barrett · Grand Cayman, Cayman IslandsDirectorLewis Teal · Vancouver, British Columbia, CanadaDirectorRichard Harris · NEW YORK, NYExec · DirectorShehzad Khan · NEW YORK, NYDirectorMark Floyd · Plano, TXDirectorAndrew T. Basham · Richmond, VADirectorS. T. Williams · Richmond, VADirectorSunriver Management LLC · Greenwich, CTDirectorSunriver GP LLC · Greenwich, CTExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗